Top 5 Dividend Stocks To Invest In 2015: Merck & Company Inc.(MRK)
Merck & Co., Inc. provides various health solutions through its prescription medicines, vaccines, biologic therapies, animal health, and consumer care products. The company?s Pharmaceutical segment provides human health pharmaceutical products, such as therapeutic and preventive agents for the treatment of human disorders in the areas of bone, respiratory, immunology, dermatology, cardiovascular, diabetes and obesity, infectious diseases, neurosciences and ophthalmology, oncology, vaccines, and women's health and endocrine. This segment also offers human health vaccines, such as preventive pediatric, adolescent, and adult vaccines. Its Animal Health segment discovers, develops, manufactures, and markets animal health products. This segment offers antibiotics, anti-inflammatory products, vaccines, products for the treatment of fertility disorders, and parasiticides for cattle, swine, horses, poultry, dogs, cats, salmons, and fish. The Consumer Care segment develops, manufac tures, and markets over-the-counter, foot care, and sun care products. Its over-the-counter product line includes non-drowsy antihistamines; treatment for occasional constipation; decongestant-free cold/flu medicine for people with high blood pressure; nasal decongestant spray; and treatment for frequent heartburn. This segment?s foot care products comprise topical antifungal, and foot and sneaker odor/wetness products; and sun care products include sun care lotions, sprays and dry oils; and sunburn relief products. The company serves drug wholesalers and retailers, hospitals, government agencies, physicians, physician distributors, veterinarians, animal producers, and managed health care providers, as well as food chain and mass merchandiser outlets in the United States and Canada. Merck & Co., Inc. was founded in 1891 and is headquartered in Whitehouse Station, New Jersey.Advisors' Opinion:
- [By Jessica Alling]
Mer! ck (NYSE: MRK ) is also up this morning, by 0.13%. The company is benefiting from its recent announcement that it and partner GlaxoSmithKline (NYSE: GSK ) will be reducing prices for their HPV vaccines in an effort to make them available to girls in the world's poorest regions. Providing a 95% discount from the U.S. rate, the doses of the vaccine will cost $4.50 under the new policy. HPV is the leading cause of cervical cancer in women, and to date there has been little done to try to provide the inoculations to the poorest countries, where 80% of the deaths from cervical cancer occur.
- [By Brian Pacampara]
Based on the aggregated intelligence of 180,000-plus investors participating in Motley Fool CAPS, the Fool's free investing community, drug behemoth Merck (NYSE: MRK ) has earned a respectedfour-star ranking.
- [By Marc Bastow]
Global healthcare and pharmaceutical giant Merck (MRK) raised its quarterly dividend 2.3% to 44 cents per share, payable on Jan. 8 to shareholders of record as of Dec. 16.
MRK Dividend Yield: 3.57%
- [By Brian Orelli]
There's just one problem: Generics abound
While there's an opportunity to increase the market for cholesterol drugs, it's likely going to come from generic drugs. Both Merck's (NYSE: MRK ) Zocor and Pfizer's (NYSE: PFE ) Lipitor are available as cheap generics.
source from Top Penny Stocks For 2015:http://www.seekpennystocks.com/top-5-dividend-stocks-to-invest-in-2015.html